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Abstract EmrE is an Escherichia coli 12-kDa multidrug
transporter, which confers resistance to a variety of toxic cations
by removing them from the cell interior in exchange with two
protons. EmrE has only one membrane-embedded charged
residue, Glu-14, that is conserved in more than 50 homologous
proteins and it is a simple model system to study the role of
carboxylic residues in ion-coupled transporters. We have used
mutagenesis and chemical modification to show that Glu-14 is
part of the substrate binding site. Its role in proton binding and
translocation was shown by a study of the effect of pH on ligand
binding, uptake, efflux and exchange reactions. We conclude that
Glu-14 is an essential part of a binding site, common to
substrates and protons. The occupancy of this site is mutually
exclusive and provides the basis of the simplest coupling of two
fluxes. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Transporters are responsible for creating and maintaining
the di¡erent composition of the cell interior relative to the
exterior in both prokaryotic and eukaryotic cells. This is
also the case for the solute gradients across internal organelles
such as mitochondria, synaptic vesicles and lysosomes. Some
of these transporters utilize ATP as an energy source while
others use ion electrochemical gradients to actively transport
di¡erent substrates [1^3].
In some cases malfunction of a transporter results in dis-
eases such as Bartter’s and Gitelman’s syndromes of inherited
hypokalemic alkalosis [4]. Other transporters are the targets of
therapeutic treatment: the antidepressant Prozac is a blocker
of the brain serotonin transporter. On the other hand, some
transporters prevent drug therapy: multidrug transporters
that export antineoplastic agents from cancer cells and others
responsible for removal of antibiotics from microorganisms
[2,5,6].
An increasing number of membrane protein structures, at
atomic resolution, are now becoming available, although none
of them are ion-coupled transporters. Crystallization of trans-
porters is di⁄cult since they are in a detergent solution. In
addition, it has been suggested that transporters exist in multi-
ple conformations needed for proper translocation of sub-
strates, a detrimental property for crystal formation. Alterna-
tive and complementing approaches are constantly being
developed to circumvent the lack of structural information
and to obtain sets of structural constraints that will allow
an educated guess on the structure^function relationship of
membrane transporters [7,8].
Charged residues are found in transmembrane domains of
ion-coupled transporters, even though their insertion is ener-
getically unfavorable. Those residues are probably transferred
into the bilayer as uncharged, polar molecules, after protona-
tion or deprotonation [9]. Also salt bridges between close
enough positive and negative residues can decrease the energy
required for insertion [10]. Two residues can react to form a
salt bridge if they are located one turn away in the same helix,
or in di¡erent helices which are close enough in the three-
dimensional structure. In some transporters, such as the lac
permease [11] or VMAT2 [12], some of the ion pairs were
suggested to be important for transport activity or substrate
recognition. Because of their location, charged residues in
transmembrane domains are suggested to be important for
structure or activity. In cases where substrates are charged
or polar, acidic or basic residues might play important roles
in the binding site of these substrates.
A clear role of charged residues in proton transfer has been
demonstrated in several H pumps including the light-driven
bacteriorhodopsin [13], subunit c of ATPase [14] and redox-
driven respiratory and photosynthetic complexes [15]. The en-
ergy input usually brings about a change in the protein which
modi¢es the pKa of one or more residues. This results in
protonation or deprotonation of the residue, followed by sev-
eral conformational changes enabling vectorial proton trans-
location.
A summary of the available information on the role of
carboxylic residues in several ion-coupled transporters is pre-
sented in Table 1.
As can be seen in Table 1, the position of the important
carboxylic groups varies in di¡erent transporters, in some of
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them the residues are found in the amino-terminal half, in
others in the carboxy-terminal half. The data also suggest
that in several ion-coupled transporters carboxylic residues
are involved in the binding of positively charged substrates,
whereas in other transporters carboxyls are involved in bind-
ing and translocation of the co-transported cation. In the
lactose permease, one of the best characterized ion-coupled
transporters, two carboxylic residues are important for sub-
strate binding and a di¡erent one is essential for proton bind-
ing and coupling. A simpler model system, EmrE, reveals a
unique property: a single membrane-embedded charged car-
boxyl is part of a common binding site for substrates and
protons.
2. Obligatory ‘time-sharing’ of a binding site common to
protons and substrates provides the molecular basis of
coupling in EmrE
EmrE is a member of the SMR family. This family includes
small multidrug transporters widespread in the eubacterial
Table 1
The role of carboxylic residues in ion-coupled transporters
Transporter Source Transporter function Length (aa),
number of
TMs
Carboxyl
position
General comments Reference
Residues involved in substrate binding:
MdfA E. coli Multidrug H-coupled
transport
410 residues,
12 TMs
Glu-26,
TM 1
Part of the binding pocket of
positively charged substrates
[22,23]
VMAT2, vesicular
monoamine trans-
porter 2
rat H-dependent
accumulation of
monoamines in
intracellular organelles
515 residues,
12 TMs
Asp-33,
TM 1
Involved in substrate recognition.
Conserved in vesicular
neurotransmitters and transporters
[24]
DAT, dopamine
transporter
rat Na-dependent reuptake
of dopamine from the
synapse
619 residues,
12 TMs
Asp-79,
TM 1
Involved in substrate recognition.
Conserved in catecholamine
transporters
[25,26]
Tet(B), Tn10-
encoded
tetracycline/H
antiporter
E. coli Active e¥ux of
tetracycline out of the cell
401 residues,
12 TMs
Asp-15,
TM 1;
Asp-84,
TM 3
Both residues are part of the
tetracycline binding pocket. The
Tet(A) to Tet(E) e¥ux proteins
have Asp residues in TMs 1 and 3
[27]
rOCT1 rat First step of hepatic and
renal cation excretion
556 residues,
12 TMs
Glu-475,
TM 11
Conserved in the OCT-type
electrogenic cation transporters
[28]
QacA S. aureus Multidrug H-coupled
transport.
514 residues,
14 TMs
Asp-323,
TM 10
Important for divalent organic
cation recognition
[29]
Residues involved in the binding and translocation of co-transported cation:
MelB, melibiose
carrier
E. coli Cation^sugar co-transport 469 residues,
12 TMs
Asp-51,
Asp-55,
Asp-120,
TMs 2, 4
The hydrophobic amino-terminal
of the transporter seems to
accommodate the cation binding
site or part of it
[30^32]
MIT, myo-inositol
transporter
Leishmania
donovani
myo-Inositol/proton
symport
547 residues,
12 TMs
Asp-19,
TM 1
Important for proton coupling,
conserved in ¢ve inositol and
sugar H-coupled symporters,
from bacteria yeast and protozoa
[33]
NhaA, Na/H
antiporter
E. coli Transport of Na and H
in opposite directions
across cytoplasmic
membranes
388 residues,
12 TMs
Asp-133,
TM 4
The residue plays a role in sodium
binding. Conserved in transporters
from bacteria and yeast
A. Rothman,
unpublished
observations,
[34,35]
GLT-1, glutamate
transporter
rat Na,K coupled
glutamate transport
into the cell
573 residues,
8 TMs
Asp-404,
TM 7
Critical for interaction between
K and the transporter, conserved
among all cloned mammalian
glutamate transporters
[36]
NaDC-1, Na/
dicarboxylate
co-transporter
rabbit Absorption of Krebs cycle
intermediates by kidney
and intestine
593 residues,
11 TMs
Asp-373,
TM 8;
Glu-475,
TM 9
Both residues are important for
cation selectivity
[37]
VMAT1, vesicular
monoamine trans-
porter 1
rat H-dependent
accumulation of
monoamines in
intracellular organelles
521 residues,
12 TMs
Asp-404,
TM 10;
Asp-431,
TM 11
Both residues are important for
translocation of the second proton,
after substrate binding
[38]
Residues involved in either substrate binding or cation binding and translocation:
Lactose permease E. coli H-coupled symport of
lactose or other
galactosides
417 residues,
12 TMs
Glu-325,
TM 10
The only residue that appears to
be directly involved in proton
translocation
[7,39^41]
Glu-126,
TM 4
Part of the substrate binding site
Glu-269,
TM 8
Important for conformational
changes after lactose binding
The table includes only examples in which the role of the residues was demonstrated in either substrate recognition or partial steps of the trans-
port cycle.
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kingdom [16]. They are about 100 residues long, with four
putative transmembrane helices. EmrE was shown to be a
proton-coupled multidrug transporter [17], which functions
as an oligomer, most likely a trimer [18,19].
In EmrE there are eight charged residues: ¢ve basic (Lys-
22, Arg-29, Arg-82, Arg-106 and His-110) and three acidic
(Glu-14, Glu-25 and Asp-84). Seven of these residues are lo-
cated in the hydrophilic loops and can be replaced without a
signi¢cant decrease in the resistance phenotype. Most of the
mutations that conserve charge (Glu^Asp and Lys^Arg inter-
conversion) have a minor e¡ect on uptake activity, measured
with the puri¢ed protein reconstituted in proteoliposomes. In
general, replacements with Cys have lower activities than the
corresponding conservative ones [20]. Glu-14 is the only
charged residue in the putative membrane domain of EmrE.
Mutation in this residue has a dramatic e¡ect on transport
activity and resistance conferred by the protein. This residue is
conserved throughout the 50 members of the family and was
shown to be important for the resistance phenotype and trans-
port activity in Smr, the Staphylococcus aureus homologue of
EmrE [21]. Substitution of the corresponding residue in Smr,
Glu-13, to either Asp or Gln eliminated most of the resistance
to both ethidium and benzalkonium and signi¢cantly de-
creased the e¥ux of tetraphenylphosphonium (TPP) out of
the cell.
In EmrE, a role for Glu-14 in substrate binding was exam-
ined also by chemical modi¢cation with carbodiimides [20].
Dicylcohexylcarbodiimide (DCCD), a carbodiimide that is
known to react in hydrophobic environments, inhibits uptake
by wild type EmrE. In contrast, 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide (EDAC), a water-soluble carbodiimide,
causes only slight inhibition even at 40-fold higher concentra-
tions. Since Glu-14 is the only carboxylic residue in the mem-
brane domain and the mutant proteins, E25C and D84C, are
inhibited in the same concentration range as the wild type
protein, it is suggested that Glu-14 is the site of action of
DCCD.
Detergent-solubilized EmrE binds TPP with high a⁄nity
(KD = 10 nM). TPP binding to wild type EmrE is inhibited
by DCCD in a dose-dependent manner (H. Yerushalmi, un-
published observations). Addition of substrates such as ethi-
dium, acri£avine and benzalkonium during the incubation
with DCCD quantitatively prevents this inactivation. We sug-
gest that substrate protection of Glu-14 re£ects the location of
this residue in or near the binding site and is most likely due
to steric hindrance. A striking demonstration that Glu-14 is
indeed central for activity is provided also by the studies of a
mutant protein with Glu-14 as a single carboxyl (EmrE E25C-
D84C). This protein is capable of conferring resistance to the
toxicants tested and, after solubilization, binds TPP with
properties similar to the wild type protein. DCCD inhibits
this binding in a substrate-protectable manner in this mutant
as well, con¢rming that Glu-14, the only carboxyl in the mu-
tant, is the site of action of DCCD. Furthermore, the proper-
ties of Glu-14 replacements reveal that the negative charge in
residue 14 is crucial for substrate recognition: the E14C mu-
tant fails to bind substrate while the E14D mutant binds to
wild type levels (KD = 35 nM) [19]. The results described
above corroborate the concept that the carboxyl at position
14 is part of the substrate binding domain.
To examine the involvement of Glu-14 in proton binding
and translocation, individual steps of the catalytic cycle were
explored. This was achieved by testing the e¡ect of pH on
TPP binding to the detergent-solubilized protein [19] and
on the uptake, e¥ux and exchange reactions [20]. TPP bind-
ing to wild type EmrE increases dramatically between pH 6.5
and 8.5, suggesting that deprotonation of the site is required
for substrate binding. On the other hand, binding to the E14D
mutant is pH-independent in this range and decreases only at
pHs below 6. These data suggest that shortening Glu to Asp
decreases the pKa of the residue to around 5, compared to the
pKa of about 7.5 in the wild type. As expected from these
¢ndings, the release of TPP from the detergent-solubilized
wild type EmrE is also a¡ected by pH. It is stimulated at
acidic pH, indicating that protonation of the binding domain
is required for substrate release. Again, the E14D mutant
shows intermediate rates of release that are pH-independent
in the ranges above pH 6.4, supporting the contention that the
pKa of the Asp at position 14 is lower than 6.
The vpH (acid inside)-driven uptake shows steep pH de-
pendence as well, increasing from undetectable values below
pH 7.5 to a maximum at pH 9.5 [20]. This is consistent with
the increasing ability of EmrE to bind substrate and release
protons at the outer surface of the proteoliposomes. The
acidic pH inside the proteoliposomes enables proper release
of the substrate and proton binding. The fact that mutant
proteins E25C, E25D, D84C and D84E display the same
pH dependence as wild type supports the conclusion that
Glu-14 is the residue involved in proton and substrate binding
and release. Similar pH dependence is observed for downhill
e¥ux and exchange. Even though these reactions are driven
solely by the substrate electrochemical gradient, binding and
release of substrate are still dependent on deprotonation and
protonation of the binding site, respectively.
When Glu-14 is replaced with Asp, uptake is dramatically
decreased. Because of the lower pKa of Asp-14, binding of
substrate is possible at acidic pHs. However, at the higher
pH range (above 6.2), binding and release of the substrate
are independent of pH. In other words, coupling between
protons and substrate is lost and therefore accumulation of
substrate at the expense of a proton gradient cannot be
achieved. As expected, E14D catalyzes downhill e¥ux and
exchange of substrate, at a maximal rate of about 30^50%
of that of the wild type protein. In addition, and unlike the
case for the wild type protein, e¥ux and exchange rates are
already maximal at pH 6.5 and stable thereafter. This, again,
is in line with our ¢ndings that in the E14D protein substrate
binding and release, above pH 6.2, do not involve changes in
the protonation state of the carboxylic residue.
We suggest that Glu-14 is an essential part of the binding
domain shared by substrates and protons. The results also
indicate that occupancy of the binding domain is mutually
exclusive. This fact provides the molecular basis for the obli-
gatory exchange catalyzed by EmrE. In our view of the alter-
native access model for EmrE, we postulate that TPP is
bound in a hydrophobic pocket via an interaction with Glu-
14 (Fig. 1). We assume that the Glu-14 residue in each mono-
mer participates in the binding, forming a charged trimeric
cluster, in which one negative charge is shared and two
charges are neutralized by protons. The permanent negative
charge in the binding site would also serve to enhance the
interaction with the positively charged substrates. The inter-
action of the substrate with the protein (binding energy) and
the cluster (maybe also electrostatic) would in£uence the latter
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in a way that might induce release of the protons. Following
this, the binding site, now occupied by the substrate, becomes
modi¢ed so that it is accessible to the other face of the mem-
brane. The interaction of the delocalized charge in the sub-
strate with the three negative charges in the protein is likely to
be strong in the hydrophobic environment of the putative
binding site. Such a stable complex can be e⁄ciently dissoci-
ated only when renewed proton binding to the cluster occurs.
After protonation and substrate release, the binding site re-
laxes back to the other face of the membrane so that a new
cycle can start.
The central role of acidic residues in membrane domains
has also been observed in many other ion-coupled transport-
ers (Table 1). Their role in substrate binding and H trans-
location has been postulated in a detailed mechanism pro-
posed for the lac permease [7]. The substrate, in this case L-
galactosides such as lactose, binds to a domain formed by
Glu-126 and other residues. Binding to this site depends on
the protonation state of Glu-325, another carboxylic acid,
with an unusually high pKa. Lactose binding induces a series
of conformational changes that bring about release of protons
from Glu-325. Several major di¡erences exist between the lat-
ter model and the one for EmrE, postulated here. In the lac
permease, substrate exchange can occur without H release
because sugar is released prior to protons. In EmrE, on the
other hand, both binding and release of substrate can occur
only upon the corresponding release or binding of protons.
These ¢ndings suggest a direct mechanism of coupling based
on the mutually exclusive occupancy of a single binding site.
In the lac permease, the two sites are suggested to be distinct
and they interact with each other through conformational
changes of the protein. Therefore EmrE shows the simplest
mode of coupling and demonstrates the advantage of this
transporter as a model system.
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